Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
Holding TELO?
Track your performance easily
TELO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.11 - $20.72
Previous Close$4.38
Volume92.44K
Average Volume (3M)135.27K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.90M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.16
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares Outstanding29,609,814
10 Day Avg. Volume56,330
30 Day Avg. Volume135,269
Standard Deviation0.33
R-Squared0.06
Alpha-0.00777
Financial Highlights & Ratios
Price to Book (P/B)83.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-20.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Telomir Pharmaceuticals, Inc. News
Ownership Overview
11.12% Insiders
0.35% Mutual Funds
0.17% Other Institutional Investors
84.35% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TELO FAQ
What was Telomir Pharmaceuticals, Inc.’s price range in the past 12 months?
Telomir Pharmaceuticals, Inc. lowest stock price was $3.11 and its highest was $20.72 in the past 12 months.
What is Telomir Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is Telomir Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Telomir Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is Telomir Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Telomir Pharmaceuticals, Inc.’s price is currently Overvalued.
Does Telomir Pharmaceuticals, Inc. pay dividends?
Telomir Pharmaceuticals, Inc. does not currently pay dividends.
What is Telomir Pharmaceuticals, Inc.’s EPS estimate?
Telomir Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telomir Pharmaceuticals, Inc. have?
Telomir Pharmaceuticals, Inc. has 29,609,814 shares outstanding.
What happened to Telomir Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Telomir Pharmaceuticals, Inc.?
Among the largest hedge funds holding Telomir Pharmaceuticals, Inc.’s share is Suncoast Equity Management. It holds Telomir Pharmaceuticals, Inc.’s shares valued at 117K.
---
Telomir Pharmaceuticals, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-686.91%
Trailing 12-Months
Asset Growth
-64.51%
Trailing 12-Months
Company Description
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oralin situtherapeutic treatment for human stem cells. Its goal is to develop and commercialize new treatment options for age-related inflammatory conditions, with hemochromatosis as its initial clinical focus, and to thereafter expand the development of TELOMIR-1 to post-chemotherapy recovery as well as a broader range of other age-related inflammatory diseases and conditions such as osteoarthritis.
---
Technical Analysis
---